News tagged with t cell lymphoma
A leukemia drug kills cancerous T-cells while sparing normal immunity
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a leukemia arising from T-cells, a type of white blood cell. This cancer can involve the skin and other organs, and patients often die within three years.
Jan 25, 2012 |
4.8 / 5 (4) |
0
|
Scientists look to immune system to handle follicular lymphoma
University of Rochester Medical Center researchers found more evidence that T cells going awry in the microenvironment – or the tissue immediately surrounding the tumor – may play a role in the biology ...
Oct 12, 2011 |
5 / 5 (3) |
0
|
Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman ...
Aug 15, 2011 |
not rated yet |
0
|
Researchers predict age of T cells to improve cancer treatment
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's ...
Mar 02, 2011 |
not rated yet |
0
|
Armed antibody triggers remissions for Hodgkin's lymphoma
An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report ...
Nov 03, 2010 |
not rated yet |
0
Control of cancer cell pathways key to halting disease spread, study shows
Oncogenes are like friends who've gone off the deep end. Normally steady, reliable members of the cellular workforce, these genes become very bad influences when mutated or expressed at high levels -- urging a cell to divide ...
Jun 14, 2010 |
5 / 5 (1) |
0
|
Improving the odds:A new method for bone marrow transplantation
Although bone marrow transplants have long been standard for acute leukemia, current treatments still rely on exact matches between donor and patient. Now, scientists at the University of Perugia, Italy, and the Weizmann ...
Dec 07, 2009 |
not rated yet |
0
Drug That Crosses Blood-Brain Barrier Reduces Formation of Brain Metastases in Mice
(PhysOrg.com) -- The drug vorinostat is able to cross the blood-brain barrier and reduce the development of large metastatic tumors in mice brains by 62 percent when compared to mice that did not receive the drug, according ...
Sep 29, 2009 |
2.5 / 5 (2) |
1
Bcl6 gene sculpts helper T cell to boost antibody production
Expression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists ...
Jul 23, 2009 |
5 / 5 (1) |
0
Researchers Formulate Treatment Combination Lethal To Pancreatic Cancer Cells (w/Video)
A combination of two targeted therapies packs a powerful punch to kill pancreatic cancer cells in the laboratory, Mayo Clinic cancer researchers report. With further testing of these drugs that are from classes of pharmaceuticals ...
Apr 20, 2009 |
not rated yet |
0
